Start / Fund / Grow
RhoDx is an early-stage biotech company focused on technology development and commercialization for the liquid biopsy, including more precise and cost-effective detection and monitoring of various forms of cancer.
Charlie Rodi, the scientific founder of RhoDx, needed cost-effective and experienced legal counsel to help launch and bootstrap this biotech company through its initial startup, funding and technology development phases. Given the groundbreaking nature of this technology, we worked with Dr. Rodi to design an alternative business arrangement with our firm, so that RhoDx would have greater possibilities to advance its technology and achieve important R&D and commercial milestones.
We have worked with RhoDx from the beginning and have assisted with its initial corporate formation, convertible debt funding, key R&D and collaboration agreements and various business, legal and related strategy matters. We are delighted to work with Dr. Rodi and to help RhoDx advance the potential of its liquid biopsy technology. We will continue to assist RhoDx with financing, licensing, team-related and other matters as it continues advancing through its funding and growth stages.
We worked with Dr. Rodi to design an alternative business arrangement with our firm, so that RhoDx has greater possibilities to advance its technology and achieve important R&D and commercial milestones. Dr. Rodi has the best possible corporate structure and strategy to support future innovation and growth.